期刊文献+

穿刺Gleason评分6~7分前列腺癌根治术后ISUP升级预测模型的建立与内部验证 被引量:1

Establishment and internal validation of nomogram for prediction of ISUP upgrading of prostate biopsy Gleason score 6 or 7
原文传递
导出
摘要 目的:穿刺Gleason评分6~7分的前列腺癌患者术后易发生国际泌尿病理学会(International Society of Urological Pathology, ISUP)升级。因此,本研究通过临床指标构建一个预测ISUP分级升级的列线图模型并进行内部验证。方法:回顾性收集我院2019年1月—2021年12月因前列腺癌行手术治疗的患者临床病理资料。根据术后ISUP分级是否升级将纳入患者分为升级组和未升级组,Student t检验及χ^(2)检验比较2组患者的临床指标,桑基图显示穿刺与术后ISUP的变化程度。通过logistic回归分析明确与ISUP升级相关的临床指标,构建术后ISUP升级的预测模型,受试者工作特征(ROC)曲线和曲线下面积用于评估模型的预测能力,校准曲线和决策曲线用于分析评估模型的准确性和临床有效性。结果:本研究共纳入155例患者。升级组和未升级组分别为79例和76例,升级比例为51.0%。在穿刺Gleason评分3+3、3+4、4+3分中,ISUP升级的比例分别为68.8%、47.1%和25.0%。预测列线图模型由体重指数(BMI)、穿刺前PSA水平、穿刺Gleason评分及临床T分期4个指标组成。ROC曲线结果显示预测模型的准确性高达0.799,校准曲线和决策曲线均提示预测模型具有一致性以及较好的临床获益。结论:由BMI、穿刺前PSA水平、穿刺Gleason评分及临床T分期4个指标构建的预测ISUP升级的列线图模型准确性相对较高,该模型有助于临床医师进行术前评估及为患者咨询提供个体化信息。 Objective Gleason score 6 or 7 of biopsy pathology tend to upgrade after radical surgery.So this study aimed to develop and internally validate a nomogram to predict ISUP upgrading.Methods Clinicopathological information of prostate cancer patients,who underwent radical prostatectomy between January 2019 and December 2021 in our hospital were collected retrospectively.Patients were divided into two groups according to ISUP upgrading.Student t test and Chi-square test were applied to compare clinical parameters and Sankey diagram to describe ISUP group change.A predictive nomogram,which was constructed on the basis of four clinical indicators,was evaluated by receiver operation characteristic(ROC)curve and the area under the curve,furthermore,calibration curve and decision curve analysis were performed to evaluate the accuracy and efficiency of the nomogram.Results Totally 155 patients were enrolled and the groups with and without ISUP upgrading were 79 and 76 patients,respectively.The overall proportion of upgrading was 51.0%,and the corresponding proportion of biopsy Gleason score 3+3,3+4 and 4+3 were 68.8%,47.1%and 25.0%,respectively.The predictive nomogram was based on BMI,pre-biopsy PSA value,biopsy Gleason score and clinical T stage.The accuracy of nomogram was 0.799 and calibration curve and decision curve analysis proved the robustness and satisfactory clinical benefit of predictive model.Conclusion Our study proposed a predictive nomogram for ISUP upgrading with relatively high accuracy and the nomogram was helpful for preoperative evaluation and individualized consultation.
作者 罗程 吴禹锟 韩燚超 王道虎 LUO Cheng;WU Yukun;HAN Yichao;WANG Daohu(Department of Urology,the First Affiliated Hospital of Sun Yat-sen University,Guangzhou,510080,China)
出处 《临床泌尿外科杂志》 CAS 2023年第12期948-951,共4页 Journal of Clinical Urology
关键词 前列腺癌 国际泌尿病理学会分级 根治性前列腺切除术 列线图 prostate cancer ISUP grading radical prostatectomy nomogram
  • 相关文献

参考文献3

二级参考文献19

  • 1Xu N,Xue XY,Li XD,et al.Meperidine relieves pain during transrectal ultrasound-guided prostate biopsy.Saudi Med J,2014,35(5):454-459.
  • 2Vellekoop A,Loeb S,Folkvaljon Y,et al.Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.J Urol,2014,191(2):350-357.
  • 3Alchin DR,Murphy D,Lawrentschuk N.What are the predictive factors for gleason score upgrade following RP?Urol Int,2016,96(1):1-4.
  • 4Chung MS,Lee SH,Lee DH,et al.Is small prostate volume a predictor of Gleason score upgrading after radical prostatectomy?Yonsei Med J,2013,54(4):902-906.
  • 5Patel AR,Jones JS.Optimal biopsy strategies for the diagnosis and staging of prostate cancer.Curr Opin Urol,2009,19(3):232-237.
  • 6Hong SK,Han BK,Lee ST,et al.Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via multi(>or=12)-core prostate biopsy.World J Urol,2009,27(2):271-276.
  • 7Lima NG,Soares Dde F,Rhoden EL.Importance of prostatespecific antigen(PSA)as a predictive factor for concordance between the Gleason scores of prostate biopsies and radical prostatectomy specimens.Clinics(Sao Paulo),2013,68(6):820-824.
  • 8Truong M,Slezak JA,Lin CP,et al.Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.Cancer,2013,119(22):3992-4002.
  • 9Sfoungaristos S,Katafigiotis I,Perimenis P.The role of PSA density to predict a pathological tumour upgrade between needle biopsy and radical prostatectomy for low risk clinical prostate cancer in the modified Gleason system era.Can Urol Assoc J,2013,7(11-12):E722-E727.
  • 10Magheli A,Hinz S,Hege C,et al.Prostate specific antigen density to predict prostate cancer upgrading in a contemporary radical prostatectomy series:A single center experience.J Urol,2010,183(1):126-131.

共引文献14

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部